News and media

MONTREAL, May 28, 2026 – Eighty-seven years after the diagnosis of Lou Gehrig, the famous New York baseball player, amyotrophic lateral sclerosis (ALS) remains a fatal disease: it still claims eight out of ten people within five years of diagnosis. To mark ALS Awareness Month and Lou Gehrig Day, ALS Quebec is rolling out a series of fundraising activities across Quebec to raise awareness...

The ALS Society of Canada is proud to announce the funding of a 2025 ALS Canada Discovery Grant in partnership with the ALS Québec – Dr. Jean-Pierre Canuel Fund, to support a research project led by Dr. Janice Robertson at the University of Toronto. The one-year, $125,000 grant will support Dr. Robertson and her team’s project, Mapping Alternative Polyadenylation and Splicing in ALS via...

You’ve probably heard of multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS), also known as Charcot’s disease or Lou Gehrig’s disease. Both conditions affect the nervous system, but they differ significantly in their causes, symptoms, and progression. Today, we want to clarify these distinctions to better guide,...